Argus
•
Oct 28, 2026
MEDP: Raising target price to $741.00
Summary
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms.
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Penumbra, Inc.
Oct 30, 2026
•
PEN
Analyst Report: Saia, Inc.
Oct 30, 2026
•
SAIA
Analyst Report: ICON Public Limited Company
Oct 29, 2026
•
ICLR
Analyst Report: West Pharmaceutical Services, Inc.
Oct 29, 2026
•
WST
Analyst Report: Labcorp Holdings Inc.
Oct 28, 2026
•
LH
